Altamira Therapeutics Ltd. (CYTO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Altamira Therapeutics Ltd...

    NASDAQ: CYTO · Real-Time Price · USD
    0.30
    0.00 (0.00%)
    At close: Jan 16, 2025, 10:00 PM

    Altamira Therapeutics Ratios and Metrics

    Financials in CHF. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    PE Ratio
    		 n/a n/a -0.22 -0.45 -7.74 -0.14 -0.44 -0.95 1.00 -1.25 -3.04 -3.03
    PEG Ratio
    		 n/a n/a 0.48 -0.00 0.08 -0.00 n/a 0.01 -0.00 -0.03 n/a 0.11
    PS Ratio
    		 n/a n/a 45.68 92.83 n/a -12 49.36 108.16 n/a n/a n/a n/a
    PB Ratio
    		 n/a n/a -1.32 -2.68 -2.99 -0.66 0.93 2.33 1.65 1.97 2.05 2.04
    P/FCF Ratio
    		 n/a n/a -0.62 -1.27 -16.03 -3.55 -2.57 -5.63 -8.36 -5.88 -16.72 -16.63
    P/OCF Ratio
    		 n/a n/a -0.62 -1.27 -16.03 -3.55 -2.57 -5.63 -4.79 -5.88 -16.72 -16.63
    OCF/S Ratio
    		 n/a n/a -73.15 -73.15 n/a 3.38 -19.2 -19.2 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.02 n/a -1.9 -1.84 -0.76 -0.75 0.68 0.76 0.05 0.04 n/a n/a
    Quick Ratio
    		 1.38 1.38 0.27 0.27 0.14 0.14 0.18 0.18 0.60 0.67 2.92 2.92
    Current Ratio
    		 1.38 1.38 0.32 0.32 0.14 0.14 0.20 0.20 0.77 0.84 2.98 2.98
    Asset Turnover
    		 n/a n/a 0.01 0.01 n/a -0.07 0.01 0.01 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -3.92 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Return on Equity
    		 n/a n/a 1.49 1.49 0.10 1.16 -0.54 -0.61 0.41 -0.4 -0.17 -0.17
    Return on Assets
    		 n/a n/a -0.44 -0.44 -0.13 -1.52 -0.22 -0.22 0.28 -0.27 -0.14 -0.14
    Return on Invested Capital
    		 n/a n/a -0.74 -0.77 -10.32 4.43 -0.31 -0.32 0.38 -0.31 -0.16 -0.16
    Dividend Yield
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a -1.01 -1.01 n/a 1.27 -3.1 -3.1 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a -51.4 -51.4 n/a 20.95 -28.33 -28.33 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a -51.3 -51.3 n/a 20.91 -28.49 -28.49 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a -43.48 -43.48 n/a 6.81 -28.94 -28.94 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a -7.81 -7.81 n/a 6.81 -28.94 -28.94 n/a n/a n/a n/a

    Add to Watchlist